Do Economists Support FDA Pre-approval of Drugs?
Conventional wisdom holds that economists advocate for reducing regulation on most policy arenas. Regulation imposes costs and businesses and is often ineffective. Further, as technology and market conditions change, regulations which were originally welfare enhancing can now become archane. The public generally views the FDA’s pre-approval as a worthwhile endeavor. The goal of FDA pre-approval…